Yuko Tamaki

Safety and efficacy of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Japanese patients with hypertension and renal dysfunction

Sadayoshi Ito, Minoru Satoh, Yuko Tamaki et al. · Hypertension Research · 2015 · 105 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Saccadic eye movements evoked by microstimulation of the fastigial nucleus of macaque monkeys

Hirofumi Noda, Shinji Murakami, Jinzo Yamada et al. · Journal of Neurophysiology · 1988 · 77 citations

Life Sciences, Neurobiology, Neuroscience +16

Add-On Omalizumab for Inadequately Controlled Severe Pollinosis Despite Standard-of-Care: A Randomized Study

Kimihiro Okubo, Mitsuhiro Okano, Norio Sato et al. · The Journal of Allergy and Clinical Immunology In Practice · 2020 · 53 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

<scp>LCZ</scp>696, a First‐in‐Class Angiotensin Receptor‐Neprilysin Inhibitor: The First Clinical Experience in Patients With Severe Hypertension

Kazuomi Kario, Yuko Tamaki, Naoko Okino et al. · Journal of Clinical Hypertension · 2015 · 47 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Activity patterns of the suprahyoid muscles during swallowing of different fluid volumes

Yozo Miyaoka, Ichiro Ashida, Shoji Kawakami et al. · Journal of Oral Rehabilitation · 2010 · 35 citations

Health Professions, Physiology, Speech-language Pathology +17